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An Opportunity for Clarity*Vinay Badhwar, MD,y Jeffrey P. Jacobs, MDzT here remains little doubt that morbidityfrom health care–associated infections (HAI)following cardiac surgery exacts substantial
clinical and economic impact, justifying ongoing tar-
geted strategies for quality improvement (1). Howev-
er, despite the rising comorbidity proﬁle of patients
requiring cardiac surgery in the United States, there
has been a substantive decline in the prevalence of
major postoperative infections in recent years. In
the current era of transparency of outcomes and
public reporting, augmented data-driven awareness
of the impact of preventive measures, such as
appropriate-use criteria for antibiotics, perioperative
blood sugar control, and blood conservation, has
justly made infection deterrence a priority of all pro-
grams performing cardiac surgery (2–4). Although
center-level variance exists, the current overall HAI
rates following cardiac surgery are at an all-time low
of <1% for septicemia and deep sternal wound infec-
tion (DSWI) and <5% for pneumonia (4–6). Despite
these achievements, opportunity still exists for clarity
between clinical data, claims data, and homogeneity
when approaching the occasionally challenging diag-
nostic dilemma of infection in postoperative cardiac
surgical patients.SEE PAGE 15In this issue of the Journal, Greco et al. (7)
elegantly present an analysis of data from 4,320
adult patients undergoing a broad array of cardiac
operations between February 2010 and October 2010,*Editorials published in the Journal of the American College of Cardiology
reﬂect the views of the authors and do not necessarily represent the
views of JACC or the American College of Cardiology.
From the yDivision of Cardiac Surgery, Presbyterian University Hospital,
University of Pittsburgh, Pittsburgh, Pennsylvania; and the zJohns
Hopkins University, All Children’s Hospital, St. Petersburg, Florida. Both
authors have reported that they have no relationships relevant to the
contents of this paper to disclose.in order to evaluate the cost and prevalence of HAI for
up to 65 days following surgery. In an attempt to
address some of the important known limitations of a
purely claims-based examination of infection using
International Classiﬁcation of Diseases-Ninth Edition
codes, the authors from the Cardiothoracic Surgery
Trials Network pooled clinical data from cardiac op-
erations from nine U.S. academic institutions and
linked independent, de-identiﬁed, patient-level ﬁ-
nancial charges. They applied infection deﬁnitions to
the clinical data using criteria set forth by the Centers
for Disease Control and Prevention (CDC) and the
National Healthcare Safety Network. They estimated
costs from charges by using institutional cost-to-
charge ratios on the basis of annual hospital Medi-
care cost reports. Through information available to
the authors, they applied a best-in-class, generalized
linear model to statistically estimate the cost of
deﬁned infections. The result was that, despite the
relatively low 2.8% overall incidence of HAI, the
assailing cost of index admissions and readmissions
highlight the importance of infection following car-
diac surgery in value-based health care delivery.
Center-level quality-improvement protocols to
mitigate infectious complications following cardiac
surgery stem from national quality initiatives on the
basis of detailed clinical analyses of homogeneous,
nonemergent, primary risk-adjusted operations. In
the current study, the authors included all forms of
cardiac operations in the analysis. Elective, urgent,
emergent coronary artery bypass grafting (CABG)
operations; valve plus CABG; cardiac transplantation;
and ventricular assist device (VAD) operations were
all examined in those patients without acute pre-
operative infections. Major well-known predictors of
infections were identiﬁed. Patients with heart failure,
lower ejection fraction, systemic corticosteroid use,
repeat operations, urgent or emergent status, and/or
transplantation or VAD ex- or implantation all had
signiﬁcantly increased infection rates. In fairness to
TABLE 1 Infection Rates Following Adult Cardiac Operations in 2013
Infection
CABG
(n ¼ 146,498)
Valve*
(n ¼ 43,565)
Valve þ CABG†
(n ¼ 25,226)
Cardiac Transplant
(n ¼ 437)
Ventricular Assist Device‡
(n ¼ 2,103)
Deep sternal wound infection
Yes 309 (0.21) 40 (0.09) 57 (0.23) 4 (0.92) 7 (0.33)
No 145,878 (99.58) 43,421 (99.67) 25,091 (99.46) 394 (90.16) 2,020 (96.05)
Data unavailable 311 (0.21) 104 (0.24) 78 (0.31) 39 (8.92) 76 (3.61)
Pneumonia
Yes 4,116 (2.81) 1,103 (2.53) 1,239 (4.91) 32 (7.32) 199 (9.46)
No 142,090 (96.99) 42,359 (97.23) 23,912 (94.79) 366 (83.75) 1,832 (87.11)
Data unavailable 292 (0.20) 103 (0.24) 75 (0.30) 39 (8.92) 72 (3.42)
Sepsis (positive blood cultures)
Yes 633 (0.43) 233 (0.53) 214 (0.85) 24 (5.49) 90 (4.28)
No 145,304 (99.18) 43,136 (99.02) 24,877 (98.62) 374 (85.58) 1,935 (92.01)
Data unavailable 561 (0.38) 196 (0.45) 135 (0.54) 39 (8.92) 78 (3.71)
Values are n (%). This analysis from the Society of Thoracic Surgeons’ Adult Cardiac Surgery Database examined data from 217,829 cardiac operations between January 1, 2013,
to December 31, 2013, inclusive, for major health care-associated infections, stratiﬁed by procedure type. Excludes patients with active endocarditis. *Includes any isolated
aortic valve implantation, mitral valve replacement, or mitral valve repair. †Includes any isolated aortic valve implantation þ CABG, mitral valve replacement þ CABG, or mitral
valve repair þ CABG. ‡Includes any implant, explant, or implant þ explant.
CABG ¼ coronary artery bypass grafting surgery.
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25the authors, their objective was to estimate the broad
economic burden of HAI following cardiac surgery.
This ﬁrst step in affecting quality improvement ap-
pears to have been nicely realized. Although the au-
thors attempt to statistically justify the validity of
including transplant and VAD operations through cost
estimations from generalized linear modeling, the
clinical reality remains that the inclusion of these
patients known to be at exceedingly high risk for
infection and readmission was an apples-to-oranges,
or at least an apples-to-pears, comparison. Before
recommendations are made about how the develop-
ment of infections following cardiac surgery might be
addressed in health care policy and hospital-level
reimbursement, further procedure-speciﬁc granu-
larity is required.
We therefore applied the similar criteria outlined
in current study by Greco et al. (7) to an examination
of the most recent annual data from the Society of
Thoracic Surgeons’ (STS) Adult Cardiac Surgery
Database. After excluding cases of active endocardi-
tis, we reviewed 217,829 cardiac operations per-
formed between January 1, 2013, and December 31,
2013, inclusive. The overall prevalence of HAI across
all operation types was 3.8%. However, expected
signiﬁcant differences in infections were observed
when classiﬁed by operation category (Table 1). The
overall prevalence of DSWI remained remarkably low,
at <1%, across all operations (transplantation, 0.92%;
VAD, 0.33%; isolated CABG, 0.21%; and isolated
valve, 0.09%). There were signiﬁcant differences in
the prevalence of septicemia deﬁned by positive
blood cultures, the highest being for transplantationand VAD operation (transplantation, 5.49%; VAD,
4.28%; valve, 0.53%; and CABG, 0.43%; p < 0.0001).
A similar important trend was observed for post-
operative pneumonia (9.46%, VAD; 7.32%, transplant;
CABG, 2.81%; and valve, 2.53%; p < 0.0001).
These new data from the STS Adult Cardiac Surgery
Database and the observations of the current study
together highlight another important future consid-
eration for the interpretation and study of infections
after cardiac operations. The diagnosis of infections
deﬁned as clinically and economically important to
cardiac surgical programs and cardiothoracic sur-
geons, and those currently deﬁned by the CDC/
National Healthcare Safety Network for all forms of
surgery as used in this study (8), have room for
specialty-speciﬁc clarity.
To illustrate, let us review a common clinical
scenario. Following thoracic incisions for cardiac
surgery, patients commonly develop pulmonary
atelectasis often mixed with basilar effusions. This
fairly routine situation may often occur a few days
following cardiac surgery, when a patient may still
be on oxygen, with low-grade fever and leukocy-
tosis, with a radiologic appearance of consolidation
or atelectasis while expectorating sputum. To the
experienced cardiothoracic surgeon, this scenario is
completely consistent with routine postoperative
atelectasis that will resolve with physical therapy of
the chest and conservative management. However,
the factors outlined in this everyday example also
may meet the current CDC deﬁnition of clinically
deﬁned pneumonia (PNU1). Health care providers
not experienced with patients following cardiac
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26surgery, let alone immunosuppressed transplant re-
cipients, may be quick to treat with antibiotics only
for these to be discontinued rapidly once the atelec-
tasis or effusion resolves. Similarly, hospital coders
and allied health infection control providers may
wish to code this as pneumonia, as it may been
seen as administratively advantageous for morbidity
indices.
This relatively common incongruence of clinical
and administrative data objectives is one example of
potential misinterpretation of the presence and rele-
vance of infection following cardiac operations (9).
To collaboratively address this unique situation, the
STS and CDC recently entered into discussions with
the goal of harmonizing deﬁnitions of infections
speciﬁc to cardiac surgical patients, such as those of
pneumonia and DSWI. These harmonized deﬁnitionswill involve both the numerator (deﬁnition of cardiac
surgical infections) and the denominator (deﬁnition
of eligible cardiac surgical operations) necessary to
calculate the rates of infection associated with adult
and pediatric cardiac surgery.
Once this opportunity for clarity is realized, further
risk-adjusted, operation-speciﬁc study of the impact
of infection following cardiac surgery may be unam-
biguously translated to tangible hospital-level im-
provements in outcome, cost, and quality.
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